Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01467271 · ClinicalTrials.gov registry record
Observational Study on the Incidence of NSF in Renal Impaired Patients Following Dotarem Administration
A clinical trial, sponsored by Guerbet.
- Completed
- Registry status
- 540
- Enrollment target
NCT01467271 is a clinical trial that has completed, run by Guerbet. The registered enrollment target is 540 participants.
The verdict
NCT01467271 has completed, sponsored by Guerbet.
- COMPLETED
- Registry status
- 540 participants
- Enrollment target
Study Summary
The main purpose of this study is to prospectively estimate the incidence of Nephrogenic Systemic Fibrosis (NSF) in patients with moderate to severe renal impairment after administration of Dotarem®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 540 participants |
| Start Date | 2011-05 |
| Est. Completion | 2017-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01467271
The ClinicalTrials.gov registry entry for NCT01467271 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 540 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Guerbet, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01467271 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01467271 about?
NCT01467271 is a clinical study titled "Observational Study on the Incidence of NSF in Renal Impaired Patients Following Dotarem Administration". The main purpose of this study is to prospectively estimate the incidence of Nephrogenic Systemic Fibrosis (NSF) in patients with moderate to severe renal impairment after administration of Dotarem®
What is the current status of trial NCT01467271?
This trial is currently completed. The enrollment target is 540 participants. The study started on 2011-05. Estimated completion is 2017-06.
Who is sponsoring clinical trial NCT01467271?
This trial is sponsored by Guerbet, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.